Mid-Size Pharmaceutical Market
Mid-Size Pharmaceutical Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Mid-Size Pharmaceutical Market Size and Growth
Mid-size pharmaceutical market research indicates robust growth driven by increasing demand for innovative therapies and an aging population. The market size is estimated to reach approximately $120 billion by 2025, reflecting a compound annual growth rate (CAGR) of 6% due to expanding R&D investments and strategic collaborations within the industry.
Companies Covered
(Covid 19 Impact Covered)
◍ DAIICHI SANKYO COMPANY LIMITED
◍ Eisai Co.
◍ Ltd.
◍ Bausch Health Companies Inc.
◍ Regeneron Pharmaceuticals
◍ Inc
◍ Sun Pharmaceutical Industries Ltd
◍ Alexion Pharmaceuticals
◍ Inc.
◍ Mallinckrodt
◍ Endo Pharmaceuticals Inc.
◍ Les Laboratories Servier
◍ UCB S.A.
The mid-size pharmaceutical market features companies like Daiichi Sankyo, Eisai, and Bausch Health. These firms focus on specialty drugs, generics, and innovations, driving market growth through diverse portfolios. Key players enhance accessibility and address specific health needs, thus contributing significantly to revenue and market dynamics. Selected revenue figures include:
- Regeneron Pharmaceuticals: $9.7 billion
- Sun Pharmaceuticals: $4.6 billion - UCB S.A.: $5.6 billion
Request Sample Report
Market Segmentation
By Application
Cardiovascular Diseases
Pain Management
Diabetes
Cancer
Others
Request Sample Report
By Product
Prescription
Over-the-Counter (OTC)
Market Growth
Request Sample Report
$ X Billion USD
